Cargando…

The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study

PURPOSE: Accumulated studies revealed that electromagnetic field can affect human brain and sleep, and the extremely low-frequency electromagnetic field, Schumann resonance, may have the potential to reduce insomnia symptoms. The purpose of this study was to investigate the responses of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yu-Shu, Tang, I, Chin, Wei-Chih, Jang, Ling-Sheng, Lee, Chin-Pang, Lin, Chen, Yang, Chun-Pai, Cho, Shu-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189153/
https://www.ncbi.nlm.nih.gov/pubmed/35707548
http://dx.doi.org/10.2147/NSS.S346941
_version_ 1784725521620271104
author Huang, Yu-Shu
Tang, I
Chin, Wei-Chih
Jang, Ling-Sheng
Lee, Chin-Pang
Lin, Chen
Yang, Chun-Pai
Cho, Shu-Ling
author_facet Huang, Yu-Shu
Tang, I
Chin, Wei-Chih
Jang, Ling-Sheng
Lee, Chin-Pang
Lin, Chen
Yang, Chun-Pai
Cho, Shu-Ling
author_sort Huang, Yu-Shu
collection PubMed
description PURPOSE: Accumulated studies revealed that electromagnetic field can affect human brain and sleep, and the extremely low-frequency electromagnetic field, Schumann resonance, may have the potential to reduce insomnia symptoms. The purpose of this study was to investigate the responses of patients with insomnia to a non-invasive treatment, Schumann resonance (SR), and to evaluate its effectiveness by subjective and objective sleep assessments. PATIENTS AND METHODS: We adopted a double-blinded and randomized design and 40 participants (70% female; 50.00 ± 13.38 year) with insomnia completed the entire study. These participants were divided into the SR-sleep-device group and the placebo-device group and were followed up for four weeks. The study used polysomnography (PSG) to measure objective sleep and used sleep diaries, Pittsburgh Sleep Quality Inventory (PSQI), Epworth Sleepiness Scale (ESS), and visual analogy of sleep satisfaction to measure subjective sleep. The 36-Item Short-Form Health Survey (SF-36) was used to evaluate quality of life. Chi-square test, Mann–Whitney U-test, and Wilcoxon test were used to analyze the data. RESULTS: About 70% of the subjects were women, with an average age of 50±13.38 years and an average history of insomnia of 9.68±8.86 years. We found that in the SR-sleep-device group, objective sleep measurements (sleep-onset-latency, SOL, and total-sleep-time, TST) and subjective sleep questionnaires (SOL, TST, sleep-efficiency, sleep-quality, daytime-sleepiness, and sleep-satisfaction) were significantly improved after using the SR-sleep-device; in the placebo-device group, only such subjective sleep improvements as PSQI and sleep-satisfaction were observed. CONCLUSION: This study demonstrates that the SR-sleep-device can reduce the insomnia symptoms through both objective and subjective tests, with minimal adverse effects. Future studies can explore the possible mechanism of SR and health effects and, with a longer tracking time, verify the effectiveness and side effects.
format Online
Article
Text
id pubmed-9189153
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-91891532022-06-14 The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study Huang, Yu-Shu Tang, I Chin, Wei-Chih Jang, Ling-Sheng Lee, Chin-Pang Lin, Chen Yang, Chun-Pai Cho, Shu-Ling Nat Sci Sleep Original Research PURPOSE: Accumulated studies revealed that electromagnetic field can affect human brain and sleep, and the extremely low-frequency electromagnetic field, Schumann resonance, may have the potential to reduce insomnia symptoms. The purpose of this study was to investigate the responses of patients with insomnia to a non-invasive treatment, Schumann resonance (SR), and to evaluate its effectiveness by subjective and objective sleep assessments. PATIENTS AND METHODS: We adopted a double-blinded and randomized design and 40 participants (70% female; 50.00 ± 13.38 year) with insomnia completed the entire study. These participants were divided into the SR-sleep-device group and the placebo-device group and were followed up for four weeks. The study used polysomnography (PSG) to measure objective sleep and used sleep diaries, Pittsburgh Sleep Quality Inventory (PSQI), Epworth Sleepiness Scale (ESS), and visual analogy of sleep satisfaction to measure subjective sleep. The 36-Item Short-Form Health Survey (SF-36) was used to evaluate quality of life. Chi-square test, Mann–Whitney U-test, and Wilcoxon test were used to analyze the data. RESULTS: About 70% of the subjects were women, with an average age of 50±13.38 years and an average history of insomnia of 9.68±8.86 years. We found that in the SR-sleep-device group, objective sleep measurements (sleep-onset-latency, SOL, and total-sleep-time, TST) and subjective sleep questionnaires (SOL, TST, sleep-efficiency, sleep-quality, daytime-sleepiness, and sleep-satisfaction) were significantly improved after using the SR-sleep-device; in the placebo-device group, only such subjective sleep improvements as PSQI and sleep-satisfaction were observed. CONCLUSION: This study demonstrates that the SR-sleep-device can reduce the insomnia symptoms through both objective and subjective tests, with minimal adverse effects. Future studies can explore the possible mechanism of SR and health effects and, with a longer tracking time, verify the effectiveness and side effects. Dove 2022-06-08 /pmc/articles/PMC9189153/ /pubmed/35707548 http://dx.doi.org/10.2147/NSS.S346941 Text en © 2022 Huang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Huang, Yu-Shu
Tang, I
Chin, Wei-Chih
Jang, Ling-Sheng
Lee, Chin-Pang
Lin, Chen
Yang, Chun-Pai
Cho, Shu-Ling
The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study
title The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study
title_full The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study
title_fullStr The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study
title_full_unstemmed The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study
title_short The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study
title_sort subjective and objective improvement of non-invasive treatment of schumann resonance in insomnia—a randomized and double-blinded study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189153/
https://www.ncbi.nlm.nih.gov/pubmed/35707548
http://dx.doi.org/10.2147/NSS.S346941
work_keys_str_mv AT huangyushu thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT tangi thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT chinweichih thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT janglingsheng thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT leechinpang thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT linchen thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT yangchunpai thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT choshuling thesubjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT huangyushu subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT tangi subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT chinweichih subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT janglingsheng subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT leechinpang subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT linchen subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT yangchunpai subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy
AT choshuling subjectiveandobjectiveimprovementofnoninvasivetreatmentofschumannresonanceininsomniaarandomizedanddoubleblindedstudy